Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Panacea Pharmaceuticals, Inc.

Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer.The Company's core technologies exploit changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation.
We perform our in-house research and development activities at our 11,000 square foot facility in Gaithersburg, Maryland, which includes a GLP/GMP CLIA laboratory.
The Company also conducts research through Collaborative Research and other agreements with M.D. Anderson Cancer Center in Houston, Texas; Walter Reed Army Institute of Research in Bethesda, Maryland; Massachusetts Institute of Technology in Boston, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.


Contact Details:
207 Perry Parkway, Suite 2
Gaithersburg
Maryland
20877
United States of America
Tel:240.243.8000
Fax:240.465.0450
Email:info@PanaceaPharma.com
WWW:

www.panaceapharma.com/




Loading...

Press Releases on Panacea Pharmaceuticals, Inc.:

BioPortfolio Logo
Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3rd September, 2008 Panacea Pharmaceuticals, Inc.
GAITHERSBURG, Md., Sept. 3 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs 5th August, 2008 Panacea Pharmaceuticals, Inc.
GAITHERSBURG, Md., Aug. 5 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs. Ms. Sensabaugh will assume

BioNews Results for Panacea Pharmaceuticals, Inc.:

President of Panacea Pharmaceuticals resigns
Houston Business Journal:  Oct 14 2009 6:18PM Matching: panacea pharmaceuticals inc
President of Panacea Pharmaceuticals resigns
Biz Journals:  Oct 12 2009 11:16PM Matching: panacea pharmaceuticals inc
President of Panacea Pharmaceuticals resigns
San Francisco Business Times:  Oct 13 2009 12:43AM Matching: panacea pharmaceuticals inc

Panacea Pharmaceuticals, Inc. Patents:

US Patent No.Title
7605133 Isolated peptides to treat alpha-synuclein diseases
7521479 Methods of treating prion disease in mammals
7456179 Methods of treating ischemic related conditions
6780971 Compositions for inhibiting the aggregation pathway of .alpha.-synuclein

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 211 times since April 2007, the link to the organisation's website has been followed 57 times

Search for more companies in Gaithersburg

Search for more companies in Maryland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Panacea Pharmaceuticals, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.